Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy

Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan‐cancer analysis

(2020) Haijing Liu et al.   Cancer Communications

Nanoarchitectured Structure and Surface Biofunctionality of Mesoporous Silica Nanoparticles

(2020) Ranjith Kumar Kankala et al.   ADVANCED MATERIALS

EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy

(2020) Yi Bao et al.   Nature Communications

Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

(2019) Jiangsheng Xu et al.   Nature Nanotechnology

Mesoporous Silica Nanoparticles for Drug Delivery

(2019) Miguel Manzano et al.   ADVANCED FUNCTIONAL MATERIALS

A view on drug resistance in cancer

(2019) Neil Vasan et al.   NATURE

EGFR-mediated autophagy in tumourigenesis and therapeutic resistance

(2019) Min Wu et al.   CANCER LETTERS

Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis

(2018) Galileo A. Gonzalez-Conchas et al.   CANCER TREATMENT REVIEWS

Addressing Drug Resistance in Cancer with Macromolecular Chemotherapeutic Agents

(2018) Nathaniel H. Park et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

The great escape: how cationic polyplexes overcome the endosomal barrier

(2018) Tanja Bus et al.   Journal of Materials Chemistry B

Tuning pore size of mesoporous silica nanoparticles simply by varying reaction parameters

(2017) Yongju He et al.   JOURNAL OF NON-CRYSTALLINE SOLIDS

Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment

(2017) Navid Ahmadi Nasab et al.   Artificial Cells Nanomedicine and Biotechnology

Fabrication and characterization of carboxylated starch-chitosan bioactive scaffold for bone regeneration

(2016) Sepideh Shahriarpanah et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Aptamers: A promising chemical antibody for cancer therapy

(2016) Gang Zhou et al.   Oncotarget

Carboxymethyl chitosan represses tumor angiogenesis in vitro and in vivo

(2015) Zhiwen Jiang et al.   CARBOHYDRATE POLYMERS

Selective Uptake and Imaging of Aptamer- and Antibody-Conjugated Hollow Nanospheres Targeted to Epidermal Growth Factor Receptors Overexpressed in Head and Neck Cancer

(2014) Marites Pasuelo Melancon et al.   ACS Nano

Investigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency

(2014) Edward A. Sykes et al.   ACS Nano

Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer

(2014) H J Lee et al.   BRITISH JOURNAL OF CANCER

Development of pH-responsive chitosan-coated mesoporous silica nanoparticles

(2014) Muhammad Gulfam et al.   MACROMOLECULAR RESEARCH

High EGFR gene copy number predicts poor outcome in triple-negative breast cancer

(2014) Heae Surng Park et al.   MODERN PATHOLOGY

Progress in Aptamer-Mediated Drug Delivery Vehicles for Cancer Targeting and Its Implications in Addressing Chemotherapeutic Challenges

(2014) Jie Zhu et al.   Theranostics

Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy

(2014) Hongguang Sun et al.   Molecular Therapy-Nucleic Acids

Biocompatible, Uniform, and Redispersible Mesoporous Silica Nanoparticles for Cancer-Targeted Drug Delivery In Vivo

(2013) Quan Zhang et al.   ADVANCED FUNCTIONAL MATERIALS

Acidic extracellular microenvironment and cancer

(2013) Yasumasa Kato et al.   Cancer Cell International

The application of aptamers in cancer research: an up-to-date review

(2013) Meidi Hu et al.   Future Oncology

Understanding magnetic nanoparticle osteoblast receptor-mediated endocytosis using experiments and modeling

(2013) Nhiem Tran et al.   NANOTECHNOLOGY

The quest to overcome resistance to EGFR-targeted therapies in cancer

(2013) Curtis R Chong et al.   NATURE MEDICINE

A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles

(2012) Amirali Popat et al.   JOURNAL OF MATERIALS CHEMISTRY

Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs

(2012) F Henjes et al.   Oncogenesis

Aptamer-conjugated nanomaterials and their applications

(2011) Liu Yang et al.   ADVANCED DRUG DELIVERY REVIEWS

Hollow chitosan–silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy

(2011) Ziwei Deng et al.   BIOMATERIALS

The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability

(2010) Archibald Paillard et al.   BIOMATERIALS

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals

(2010) Jie Lu et al.   Small

Mechanisms of Endocytosis

(2009) Gary J. Doherty et al.   Annual Review of Biochemistry

Ligand-based targeted therapy for cancer tissue

(2009) Manasi Das et al.   Expert Opinion on Drug Delivery

Effect of Surface Properties on Nanoparticle–Cell Interactions

(2009) Ayush Verma et al.   Small

Active targeting schemes for nanoparticle systems in cancer therapeutics

(2008) James D. Byrne et al.   ADVANCED DRUG DELIVERY REVIEWS

Size-Dependent Endocytosis of Nanoparticles

(2008) Sulin Zhang et al.   ADVANCED MATERIALS

HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

(2008) Dorte Lisbet Nielsen et al.   CANCER TREATMENT REVIEWS

Nanoparticle-mediated cellular response is size-dependent

(2008) Wen Jiang et al.   Nature Nanotechnology